phenylbutazone has been researched along with Arterial Occlusive Diseases in 3 studies
Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Matoso, L | 1 |
Balagué, F | 1 |
Posmantir, A | 1 |
Kreyenbühl, W | 1 |
Fuss-Berkovits, J | 1 |
Radi, I | 1 |
Fregnan, GB | 1 |
Chieli, T | 1 |
Gnad, HD | 1 |
3 other studies available for phenylbutazone and Arterial Occlusive Diseases
Article | Year |
---|---|
[Pseudosciatica].
Topics: Adolescent; Adult; Aged; Arterial Occlusive Diseases; Carcinoma, Squamous Cell; Female; Humans; Ilia | 1978 |
The effect of a new anti-inflammatory agent, the ethoxy methyl ester of N-(2,6-dichloro-m-tolyl)-anthranilic acid (A3), on platelet behaviour "in vivo" and "in vitro".
Topics: Administration, Oral; Administration, Topical; Animals; Anti-Inflammatory Agents; Arterial Occlusive | 1975 |
[Drugs with unwanted side-effects on the retinal vessels (author's transl)].
Topics: Adult; Arterial Occlusive Diseases; Chloramphenicol; Contraceptives, Oral; Drug-Related Side Effects | 1975 |